160 Health International Limited filed its Monthly Return for the period ended 30 April 2026, confirming that no changes occurred in either authorised or issued share capital during the month.

Authorised Capital • Authorised share capital remained at 25.00 billion ordinary shares with a par value of USD 0.000002, equivalent to USD 50,000. • No increase or decrease was recorded in April 2026.

Issued Share Capital and Treasury Shares • Issued shares stayed at 336.45 million; the company held no treasury shares. • Consequently, total issued shares, excluding treasury shares, were unchanged versus March 2026. • There were no share repurchases, cancellations, or new issuances.

Public Float Compliance • The company confirmed compliance with the Main Board’s minimum public-float requirement—at least 25 % of issued shares—at month-end.

Equity-linked Instruments • Pre-IPO Share Option Scheme (effective 31 August 2023) carried 31.18 million outstanding options, split between 14.49 million options over new shares and 16.70 million over existing shares. • No options were exercised, granted, or lapsed in April, leaving potential dilution unchanged.

Other Securities • The issuer reported no warrants, convertible securities, Hong Kong Depositary Receipts, or other share-related arrangements during the month.

With stable share metrics and confirmed public-float sufficiency, 160 Health maintains an unchanged equity structure as of 30 April 2026.